Long Ideas - Since pricing its latest public offering at $5.50 two weeks ago, shares of Synergy Pharmaceuticals (SGYP) have failed to hold that print and are trading … Continue Reading
Read nowMost Popular - Exact Sciences (EXAS) on Thursday released the long-awaited results of its DeeP-C trial examining the use of its Cologuard test in the detection of CRC … Continue Reading
Read nowMost Popular - Intercept Pharmaceuticals’ (ICPT) shares immediately took off from their late October IPO price of $15 per share, soaring to a closing high of $41.70 on … Continue Reading
Read nowLong Ideas - On Tuesday, the FDA ruled that generic drug-makers are barred from selling copies of older, easily abused formulations of Purdue Pharma’s well-known pain killer OxyContin, … Continue Reading
Read nowLong Ideas - Shares of Sarepta Therapeutics (SRPT) turned volatile Monday after the close ($32-$49) as the company announced the results of its recent end-of-Phase-II meeting with the FDA, a … Continue Reading
Read nowLong Ideas - The news this week that Thermo Fisher Scientific (TMO) will be coughing up $13.6B to acquire Life Technologies’ (LIFE) finally brought to earth rumors that … Continue Reading
Read nowLong Ideas - Following PropThink’s conference call with Dr. Scott Chambers on Thursday, we’re quite comfortable with the short-term and long-term patent protection on Zerenex, Keryx’s (KERX) novel … Continue Reading
Read now